Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2010-09-17 | Dr. Nusse earned a bachelor's degree in biology in from the University of Amsterdam and a doctorate in molecular biology from the Netherlands Cancer Institute in 1980. |
2011-09-16 | Dr. Nusse earned a bachelors degree in biology and a doctorate in molecular biology. He has been a professor and department chair at Stanford University. |
2012-09-14 | Dr. Nusse earned a bachelors degree in biology and a doctorate in molecular biology. He has been a professor and chairman at Stanford University and an investigator at the Howard Hughes Medical Institute. |
2013-09-20 | Roeland Nusse, Ph.D. has served on the Company’s Board since May 2010. Dr. Nusse earned degrees in biology and molecular biology and has held academic positions. ... The Board believes Dr. Nusse is qualified to serve as a Director of the Company because of his scientific research and academic background. |
2014-09-19 | Roeland Nusse, Ph.D. has served on the Company’s Board since May 2010. Dr. Nusse earned a bachelor’s degree in biology and a doctorate in molecular biology. ... The Board believes Dr. Nusse is qualified to serve as a Director of the Company because his scientific research and academic background provide valuable strategic insight. |
2015-09-18 | Dr. Nusse earned a bachelor’s degree in biology from the University of Amsterdam and a doctorate in molecular biology from the Netherlands Cancer Institute in 1980. He did his postdoctoral fellowship at the University of California, San Francisco. Dr. Nusse has served as Chairman of the Department of Developmental Biology at Stanford University since 2007. |
2016-09-13 | Dr. Nusse earned a doctorate in molecular biology and has been a professor and researcher at Stanford University. |
2017-09-12 | Dr. Nusse is a professor and researcher in developmental biology and molecular biology. No software or programming skills are mentioned. |
2018-09-11 | Dr. Nusse earned a bachelor’s degree in biology from the University of Amsterdam and a doctorate in molecular biology from the Netherlands Cancer Institute in 1980. Among other attributes, skills and qualifications, the Board believes Dr. Nusse is qualified to serve as a Director of the Company because his scientific research and academic background provide valuable strategic insight. |
2019-09-09 | Dr. Nusse earned a bachelor’s degree in biology from the University of Amsterdam and a doctorate in molecular biology from the Netherlands Cancer Institute in 1980. He brings valuable experience to the Board from his longstanding career as a researcher and department chair at Stanford University. |
2020-09-15 | Dr. Nusse earned a bachelor’s degree in biology from the University of Amsterdam and a doctorate in molecular biology from the Netherlands Cancer Institute in 1980. |
2021-09-14 | Dr. Nusse brings valuable experience to the Board from his longstanding career as a researcher and department chair at Stanford University, including strategic leadership and scientific and industry knowledge. This experience allows him to provide the Board with insight into the Company's products, customers, and markets. Dr. Nusse also has a deep understanding of and contacts within the international life science research community. |
2022-09-14 | Ph.D. in molecular biology, Netherlands Cancer Institute. Dr. Nusse brings valuable experience to the Board from his longstanding career as a researcher and department chair at Stanford University. |
2023-09-13 | Ph.D. in molecular biology, Netherlands Cancer Institute. Dr. Nusse has been a professor or associate professor in the Department of Developmental Biology at Stanford University and an investigator at the Howard Hughes Medical Institute since 1990. |
2024-09-12 | Dr. Nusse brings valuable experience to the Board from his longstanding career as a researcher and department chair at Stanford University, including strategic leadership and scientific and industry knowledge, which gives him insight into the Company’s products, customers, and markets. |
Data sourced from SEC filings. Last updated: 2025-07-16